Adenovirus-mediated viral interleukin-10 gene transfer prevents concanavalin A-induced liver injury.

BACKGROUND AND AIM: Liver injury is closely associated with immune inflammation. Lacking immunostimulatory functions, viral interleukin-10 (vIL-10), a cellular IL-10 homologue, has been an attractive molecule for immunomodulatory therapy. We aimed to reveal a protective effect of the gene transfer of an adenoviral vector encoding vIL-10 on liver injury induced by concanavalin A. METHODS: C57BL/6J mice were intravenously injected with adenoviral vector encoding vIL-10 before concanavalin A challenge. Liver injury was assessed. Interferon-γ and interleukin-4 levels were measured by ELISA. The activation of splenic and hepatic immune cells was analysed using an MTT assay. RESULTS: Adenoviral vector encoding vIL-10 pretreatment significantly decreased concanavalin A-mediated elevations in serum alanine aminotransaminase and aspartate aminotransaminase activity, and necrotic area in liver tissues. The protective effect of adenoviral vector encoding vIL-10 was attributed to its inhibition of T cell activation, and production of interferon-γ and interleukin-4 by the immune cells. Recombinant mouse IL-10, a high homologous cytokine to vIL-10, effectively downregulated interferon-γ and interleukin-4 release by hepatic mononuclear cells. CONCLUSION: Adenovirus vector-mediated vIL-10 gene transfer can prevent concanavalin A-induced hepatic injury, minimise pro-inflammatory cytokine release, and inhibit the activation of T lymphocytes.

Activated immune cells in Parkinson's disease.

Recently, an interaction between neurodegenerative processes and the innate and adaptive immune responses has been increasingly recognized. Activation of microglia, infiltration of peripheral T lymphocytes, and T-cell interaction with microglia may strongly affect the progression of Parkinson's disease (PD) both in patients and in animal models of the disease. Here, we summarize the current knowledge regarding the role of microglia in the progression of PD. The plasticity of the microglial response is also discussed in the context of PD. In addition, we also focus on the influence of several peripheral T-cell subsets on PD progression as well as on possible pathways by which they might act. This review should help increase our understanding of the effects of innate and adaptive immune cells in the pathogenesis of PD.

Structural variation from 1D to 3D: effects of ligands and solvents on the construction of lead(II)-organic coordination polymers.

A series of Pb(II) coordination polymers [Pb(ndc)(dpp)] (1), [Pb(ndc)(ptcp)].0.5 H2O (2), [Pb(ndc)(dppz)] (3), [Pb(ndc)(tcpn)(2)] (4), [Pb2(ndc)2(tcpp)] (5), [Pb(Hndc)2].H2O (6), [Pb(ndc)(dma)] (7), [Pb(bdc)(dma)] (8), [Pb(trans-chdc)(H2O)] (9), and [Pb2(cis-chdc)2].NH(CH3)2 (10), where ndc=1,4-naphthalenedicarboxylate, dpp=4,7-diphenyl-1,10-phenanthroline, ptcp=2-phenyl-1H-1,3,7,8-tetraazacyclopenta[l]phenanthrene, dppz=dipyrido[3,2-a:2',3'-c]phenazine, tcpn=2-(1H-1,3,7,8-tetraazacyclopenta[l]phenanthren-2-yl)naphthol, tcpp=4-(1H-1,3,7,8-tetraazacyclopenta[l]phenanthren-2-yl)phenol, dma=N,N-dimethylacetamide, bdc=1,4-benzenedicarboxylate, and chdc=1,4-cyclohexanedicarboxylate, have been synthesized from a hydrothermal or solvothermal reaction system by varying the ligands or the solvents. Compounds 1-5 crystallize with an N-donor chelating ligand and an aromatic dicarboxylate linker. Compounds 1-4 are 1D polymers with different pi-pi stacking interactions, whereas compound 5 consists of 2D layers. The structures of compounds 7, 8, and 10 are 3D frameworks formed by connection of the Pb(II) centers by organic acid ligands. Compound 7 is chiral although the ndc ligand is achiral, while the framework of 8 is a typical 3D (3,4)-connected net. Compound 10 is the first example of Pb(II) wheel cluster [Pb(8)O(8)] units bridged by carboxylate groups. Compound 6 contains 1D chains which are further extended to a 3D structure by pi-pi interactions. Compound 9 consists of a 2D network constructed by Pb(II) centers and trans-chdc ligands. The structural differences between 7 and 8 and between 9 and 10 indicate the importance of solvents for framework formation of the coordination polymers. By varying the solvent the cis and trans conformations of H(2)chdc in 9 and 10 were separated completely. The photoluminescence and nonlinear optical properties of the coordination polymers have also been investigated.

Structures, photoluminescence, up-conversion, and magnetism of 2D and 3D rare-earth coordination polymers with multicarboxylate linkages.

Four new rare-earth compounds, [Eu(NDC)1.5(DMF)2] (1), [Nd2(NDC)3(DMF)4].H2O (2), [La2(NDC)3(DMF)4].0.5H2O (3), and [Eu(BTC)(H2O)] (4), where NDC = 1,4-naphthalenedicarboxylate, BTC = 1,3,5-benzenetricarboxylate, and DMF = N,N-dimethylformamide, have been synthesized through preheating and cooling-down crystallization. Compounds 1-3 possess similar 2D structures, in which the NDC ligands link M(III) (M = La, Nd, and Eu) ions of two adjacent double chains constructed by NDC ligands and dinuclear M(III) building units. In compound 4, the Eu(III) ion is seven-coordinated by O atoms from six BTC ligands and one terminal water molecule in a distorted pentagonal-bipyramidal coordination environment. If the BTC ligand and the Eu(III) ion are regarded as six-connected nodes, respectively, the structure of compound 4 can be well described as a 3D six-connected net. Furthermore, compounds 1 and 4 exhibit strong red luminescence upon 355-nm excitation. Compound 2 displays interesting emissions in the near-IR region, and yellow (580 nm) pumping of this compound results in UV and intense blue emissions through an up-conversion process. The magnetic properties of compounds 1, 2, and 4 have been studied through measurement of their magnetic susceptibilities over the temperature range of 4-300 K.